Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009:4:203-23.
doi: 10.2147/copd.s3385. Epub 2009 Jun 11.

Exacerbation rate, health status and mortality in COPD--a review of potential interventions

Terence A R Seemungal  1 , John R Hurst, Jadwiga A Wedzicha
Affiliations
Review

Exacerbation rate, health status and mortality in COPD--a review of potential interventions

Terence A R Seemungal et al. Int J Chron Obstruct Pulmon Dis. 2009.

Abstract

COPD is prevalent in Western society and its incidence is rising in the developing world. Acute exacerbations of COPD, about 50% of which are unreported, lead to deterioration in quality of life and contribute significantly to disease burden. Quality of life deteriorates with time; thus, most of the health burden occurs in more severe disease. COPD severity and frequent and more severe exacerbations are all related to an increased risk of mortality. Inhaled corticosteroids (ICS) have similar effects on quality of life but ICS/long-acting bronchodilator combinations and the long-acting antimuscarinic tiotropium all improve health status and exacerbation rates and are likely to have an effect on mortality but perhaps only with prolonged use. Erythromycin has been shown to decrease the rate of COPD exacerbations. Pulmonary rehabilitation and regular physical activity are indicated in all severities of COPD and improve quality of life. Noninvasive ventilation is associated with improved quality of life. Long-term oxygen therapy improves mortality but only in hypoxic COPD patients. The choice of an inhaler device is a key component of COPD therapy and this requires more attention from physicians than perhaps we are aware of. Disease management programs, characterized as they are by patient centeredness, improve quality of life and decrease hospitalization rates. Most outcomes in COPD can be modified by interventions and these are well tolerated and have acceptable safety profiles.

Keywords: COPD; disease management program; exacerbation; exercise; health burden; inhaled steroids; long-acting antimuscarinic agents; long-acting bronchodilators; macrolide; mortality; pulmonary rehabilitation; safety; tolerability.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The interaction of safety, tolerability and efficacy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bonet T. Geneva: Sepultrechretum sive anatomica pructica ex Cadaveribus Morbo denatis, proponens Histoa’s Observations omnium pene humani corporis affectuum, ipsarcomoue Causas recordatis revelans; p. 1679.
    1. Petty TL. The history of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1:3–14. - PMC - PubMed
    1. Laennec RTH. A treatise on the diseases of the chest (English translsation for the French). Preface and notes by Forbes J. London T and G Underwood. :1837.
    1. Tiffeneau R, Pinelli AF. Aire circulant et air captif dans l’exploration de la function ventilatrice pulmonaite. Paris Med. 1947;133:624–628. - PubMed
    1. Fletcher CM, Jones NL, Burrows B, Niden AH. American emphysema and British bronchitis: A standardized comparative study. Am Rev Resp Dis. 1964;90:1–13. - PubMed

MeSH terms